Close Menu

    Subscribe to Updates

    Get the latest news information from worldwide businesses.

    What's Hot

    Thai FDA approves new treatment for gonorrhoea

    July 28, 2026

    Placenta Accreta Spectrum Risk Climbs With Rising C-Sections

    July 28, 2026

    SC says insolvency shield cannot protect real estate promoters from homebuyers’ cases

    July 28, 2026
    Facebook Instagram YouTube LinkedIn X (Twitter)
    Trending
    • Thai FDA approves new treatment for gonorrhoea
    • Placenta Accreta Spectrum Risk Climbs With Rising C-Sections
    • SC says insolvency shield cannot protect real estate promoters from homebuyers’ cases
    • US begins review of its military presence in Europe
    • 39 Amarnath Yatra pilgrims hurt as bus falls into gorge in J-K
    • U.S. Consulate in Toronto fired upon for the second time this year
    • MHT CET 2026 Final merit list released at fe2026.mahacet.org; check steps to download | Education News
    • 4-time WWE champion comes out of retirement after 3 years just before SummerSlam 2026
    Newspublicly
    • About Us
    • Advertise & Partner with us
    • Pitch Your Story
    • Contact Us
    Facebook Instagram LinkedIn X (Twitter)
    Subscribe
    • Home
    • World News
      • Asia
      • India
      • USA
      • UK & Europe
      • Middle East
    • Economy & Business
      • Global Economy
      • Corporate & Industry
      • Finance & Markets
      • Policy & Trade
    • Technology
      • Gadgets & Devices
      • Software & Apps
      • AI & Machine Learning
      • Robotics & Automation
    • Health & Medicine
      • Fitness & Nutrition
      • Research & Innovation
      • Disease & Treatment
      • Doctors, Clinics & Patient Care
    • Travel & Tourism
    • Automobile
      • Electric & Hybrid Vehicles
      • Auto Industry Insights
    • Sports
    • More
      • Education
      • Real Estate
      • Environment & Climate
      • Space & Astronomy
      • War & Conflicts
    Newspublicly
    Home»Health & Medicine»Disease & Treatment»Johnson & Johnson announces $5.5 billion settlement of talc lawsuits
    Disease & Treatment

    Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

    AdminBy AdminJuly 28, 2026No Comments2 Mins Read0 Views
    Share
    Facebook Twitter LinkedIn Copy Link WhatsApp


    J&J won a significant court victory ‌in the long-running legal battle ​last week, when a federal judge cast doubt on individual ⁠plaintiffs’ ability to prove that talc specifically caused their ovarian cancer. File

    J&J won a significant court victory ‌in the long-running legal battle ​last week, when a federal judge cast doubt on individual ⁠plaintiffs’ ability to prove that talc specifically caused their ovarian cancer. File
    | Photo Credit: Reuters

    Johnson & Johnson ​said on Monday (July 28, 2026) it has reached a $5.5 ‌billion settlement that will resolve ​tens of thousands of ⁠lawsuits alleging its baby powder and other talc products cause ovarian cancer.

    Also Read | J&J must pay $15 million to man who says its talc caused his cancer, U.S. jury finds

    J&J ‌said the settlement will resolve about 69,000 cases consolidated ‌in federal court and ‌related cases in state court, totalling 99.75% of the remaining talc claims. Plaintiffs’ law firms confirmed the deal on ​Monday (July 27), saying that ‌it was a good resolution after a decade-long court battle.

    J&J won a significant court victory ‌in the long-running legal battle ​last week, when a federal judge cast doubt on individual ⁠plaintiffs’ ability to prove that talc specifically caused their ovarian cancer.

    J&J ‌has denied that its talc products caused cancer, saying that talc was safe and did not contain asbestos. The company stopped selling talc-based baby ‌powder in the U.S. in 2020, switching ​to a cornstarch product.

    The litigation resumed in March 2025, ⁠after being put on hold for ⁠more than three years during J&J’s repeated failed attempts ‌to resolve the lawsuits through a shell company’s bankruptcy.

    Published – July 28, 2026 10:08 am IST



    Source link

    Author

    • Admin

      NewsPublicly.com is News & Articles Platform that creating SEO-focused articles on travel, lifestyle, and digital trends.

    Admin
    • Website

    NewsPublicly.com is News & Articles Platform that creating SEO-focused articles on travel, lifestyle, and digital trends.

    Related Posts

    Thai FDA approves new treatment for gonorrhoea

    July 28, 2026

    Rising malaria cases among migrant plantation workers spark concern in Kerala’s Idukki

    July 28, 2026

    No active COVID clusters in A.P., cases only sporadic, says govt.

    July 28, 2026
    Leave A Reply Cancel Reply

    Demo
    Top Posts

    The Blue Moon rises on May 30— Where and when to see the second full moon of the month

    May 30, 202640 Views

    New SOCOM rifle allows barrel swapping and cartridge changes

    June 1, 202633 Views

    “Inside Gemini Robotics 1.5: How Robots Learn to Reason & Act

    November 22, 202527 Views

    525 pounds of cocaine seized after Nebraska K9 alerts troopers on I-80

    May 28, 202624 Views
    Don't Miss

    Thai FDA approves new treatment for gonorrhoea

    July 28, 20262 Mins Read0 Views

    Thailand’s Food and Drug Administration has approved Nuzolvence (zoliflodacin), a first-in-class oral antibiotic for the…

    Placenta Accreta Spectrum Risk Climbs With Rising C-Sections

    July 28, 2026

    SC says insolvency shield cannot protect real estate promoters from homebuyers’ cases

    July 28, 2026

    US begins review of its military presence in Europe

    July 28, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • LinkedIn
    • WhatsApp

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Demo
    NEWSPUBLICLY
    Facebook X (Twitter) Instagram LinkedIn

    Home

    • About Us
    • Leadership
    • Advertise & Partner With Us
    • Pitch Your Story
    • Media Kit & Pricing
    • Career
    • FAQs

    Guidelines

    • Editorial & Submission
    • Partnership
    • Advertising & Sponsor
    • Intellectual Property Policy
    • Community & Comment
    • Security & Data Protection
    • Send Your Opinion

    Quick Links

    • Cookie Policy
    • Payment & Billing Terms
    • Refund & Cancellation
    • Copyright Policy
    • Complaint & Support
    • Sitemap
    • Contact Us

    Subscribe Us

    Get the latest news and updates!

    Copyright © 2026 Newspublicly (DIGITALIX COMMUNICATION). All Rights Reserved.
    • Privacy Policy
    • Terms of Use
    • Disclaimer